爱朋医疗：2024年公司研发投入合计金额为3327.76万元

Group 1 - The core viewpoint of the article is that Aipeng Medical (300753) has announced its R&D investment for 2024, which amounts to 33.28 million yuan, representing 8.24% of its operating revenue [1] - A new entity, Shenzhen Pengrui Brain Science, was established in August 2024 and is currently in the initial investment phase [1]